Bendamustine combined with fludarabine/cyclophosphamide as a enhanced lymphodepletion regimen demonstrates favorable efficacy and safety in CAR-T therapy for extranodal/bulky R/R B-cell lymphoma
Bendamustine combined with fludarabine/cyclophosphamide as a enhanced lymphodepletion regimen demonstrates favorable efficacy and safety in CAR-T therapy for extranodal/bulky R/R B-cell lymphoma
Yinqiang Zhang, Danying Liao, Yun Jin Kang, Wei Xie et al.
Journal
Blood
Topics
CAR-T cell therapy research
article
Bendamustine combined with fludarabine/cyclophosphamide as a enhanced lymphodepletion regimen demonstrates favorable efficacy and safety in CAR-T therapy for extranodal/bulky R/R B-cell lymphoma
Yinqiang Zhang, Danying Liao, Yun Jin Kang, Wei Xie, Lin Liu, Cong Lu, Heng Mei
article en
Abstract
No abstract available for this paper.
Publication Tag
BloodVol. 146(Supplement 1)
Institutions
Union Hospital (HK), Shanghai Cell Therapy Research Institute (CN), Huazhong University of Science and Technology (CN)